Worldwide Clinical Trials exists to transform how the world experiences Contract Research Organizations - because the path to a cure for the world's most persistent diseases isn't paved by those who play it safe. For more than 30 years, this global team of over 3,500 clinicians, scientists, and researchers has pushed boundaries, innovated, and invented to advance clinical research across all phases of drug development. The company combines deep therapeutic expertise with personalized attention, ensuring that every study receives dedicated support from senior-level experts who work directly with clients.
Every clinical trial is different, and Worldwide Clinical Trials embraces that complexity through therapeutically aligned teams specializing in rare diseases, cardiovascular and metabolic conditions, cell and gene therapy, oncology, neuroscience, and immune-mediated inflammatory diseases. From Phase I clinical pharmacology through Phase IV trials, the company delivers customized solutions - not off-the-shelf approaches - backed by scientific knowledge and operational excellence. Their mission is clear: work with passion and purpose every day to improve lives by bringing clarity to complex drug development and ensuring patients worldwide benefit from breakthrough therapies.
